Kezar Life Sciences : Failure to Satisfy Listing Rule Form 8 K

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.


As previously disclosed on a Current Report on Form 8-K filed by...

Related Keywords

,Nasdaq Stock Market ,Nasdaq Listing Qualifications Panel ,Kezar Life Sciences Inc ,Company On ,Nasdaq ,Continued Listing Rule ,Current Report ,Kezar Life Sciences ,Listing Qualifications Staff ,Nasdaq Listing Rule ,November May ,Nasdaq Capital Market ,Nasdaq Global Select Market ,Second Compliance Date ,Nasdaq Listing Qualifications ,